Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Bitter pill for drug companies.(Viewpoint)(U.S. pharmaceutical industry battles cheap imports)
- Mayor Michael Bloomberg says New York City could save millions by importing brand-name drugs from Canada, where government-imposed controls keep prices low. He may be right in the short term. But if he and others are successful, the nation's pharmace Mayor Michael Bloomberg says New York...
- Research articles 2003-11-03
- Pharma Industry Concerned Over Drug Competition Bill.(Brief Article)
- THE PHARMACEUTICAL industry is concerned over a Senate committee's approval of legislation that would require brand-name drug companies to report to federal officials any time they pay a generic manufacturer to delay market introduction of a lower- THE PHARMACEUTICAL industry is concerned over a...
- Research articles 2001-10-29
- Mylan Laboratories Seeks Change To Hatch-Waxman Provisions.
- MYLAN LABORATORIES INC., the nation's largest generic pharmaceutical manufacturer, has kicked off a campaign for "fair" pharmaceutical competition by releasing a study that says brand-name drug companies are cash-rich and do not need patent MYLAN LABORATORIES INC., the nation's largest generic pharmaceutical manufacturer, has kicked...
- Research articles 1998-07-20
- Administration, Pharma Groups Support Renewal of Pediatric Testing Measure.(Government Activity)(Brief Article)
- THE BUSH ADMINISTRATION joined thc pharmaceutical industry and patient groups last week in calling for Congress to promptly renew a four-year-old law that gives drug companies incentives to study the effects of medicines on children, an area long n THE BUSH ADMINISTRATION joined thc...
- Research articles 2001-05-14
- FDA Not to Restrict Pharma Makers From Promoting Unapproved Medicine Uses.
- IN A MAJOR VICTORY for drug companies, a federal judge has ruled that the government cannot restrict certain promotional activities by the pharmaceutical industry that encourage unapproved uses of their medicines. US District Judge Royce Lamb IN A...
- Research articles 1999-08-09
- Europe hopes to stop pharma research exodus to the US. (News: Europe).(pharmaceutical research)(Brief Article)
- EUROPE IS FORMING a united front to prevent European drug companies from transferring a growing proportion of their activities to the US. The exodus across the Atlantic, particularly of research and development (R&D) staff and facilities, EUROPE IS...
- Research articles 2002-05-20
- Drug Makers Accelerate HTS and Genomics Activities.
- Estimates say that by the year 2000, genomics will generate more than 60 percent of drug targets. THE DRUG INDUSTRY is enjoying double-digit growth, but to sustain such powerful results, pharmaceutical manufacturers are gearing up to dramatic Estimates...
- Research articles 1998-11-09
- FDA Seeks Advice From Blogger; Google Solves Pharma's Ad Problems
- The FDA sought the advice of John Mack, a blogger with 20,000 monthly readers who runs the Pharma Marketing Blog, on how drug companies should use the web to advertise their products. The agency usually likes to hear from lawyers, drug company executives and academics when it seeks regulatory advice....
- Blog posts 2009-11-12
- New Media Opportunity for Drug Firms: Video Games
- Perhaps you're tired of seeing the same healthy-looking people in drug ads hiking across craggy rocks or picking up their grandkids or wafting gently off to sleep while a slew of side effects (in fine print, natch) scrolls quickly by. If so, the pharmaceutical industry has another offer for you:...
- Blog posts 2008-09-25
- Johns Hopkins in Pharma Funding Flap
- Is Johns Hopkins University Medical School offering to endorse drug company "educational" materials for money? That was the allegation made last week by Daniel Carlat, a blogger and psychiatrist in private practice. Johns Hopkins, naturally, denies the claim. Carlat says Johns Hopkins is offering...
- Blog posts 2008-08-05
- Is There Really a "Market Price" for Drugs?
- Everyone seems to be ganging up on high drug prices these days. In two separate hearings last week, Congressional committees took after drugmakers for big markups on specialty treatments and a pharma "windfall" created by the Medicare prescription-drug benefit, while the WSJ took a hard look at the opacity of...
- Blog posts 2008-07-27
- Japanese Pharma Waves Its Charge Card
- Japanese drugmakers are anxious to expand their presence in global pharma/biotech markets where they've long been largely shut out -- and the strong yen is making it cheaper for them to basically buy their way in. Interestingly enough, some of these deals are bypassing the U.S. altogether. ...
- Blog posts 2008-06-12
- Will Online Rx Get Easier to Swallow?
- As pharmaceuticals struggle to get doctors to take their medicine, they ignore the valuable branding resources available on the web. Most pharmaceutical branding rarely goes beyond the trademarked name, at least for patients. But among the professional medical community, drug companies embrace the scope for building a more complete brand...
- White papers 2002-01-07
- Tableting and Filling Go "Inside the Box"
- As the move to increasingly selective - and potent - formulations continues, drug manufacturers are looking for new ways to protect operators from exposure to extremely potent ingredients while maintaining production efficiency. Traditionally, workers have been shielded by personnel protective equipment PPE, such as uncomfortable "space suits" that take time...
- White papers
- Oxymoron No More: The Potential of Nonprofit Drug Companies to Deliver on the Promise of Medicines for the Developing World
- Although some pharmaceutical company efforts to develop and distribute drugs in developing countries have been successful, many fall short of meeting needs in resource-poor nations. The paper discusses the concept of a nonprofit pharmaceutical company dedicated to developing and distributing drugs for diseases endemic in developing countries. Using the experience...
- White papers 2005-08-01
- IOM Report Won't Have Much Impact on Big Pharma
- The recent Institute of Medicine IOM report on the relationship between physicians and the drug industry shows how far we’ve come in the last few years, and how far we still have to go. In 2006, ten leading academicians and the head of the Association of American Medical Colleges AAMC...
- Blog posts 2009-05-14
- NPR Producer: Goodwin Broke "Ironclad" Contract Over GSK Cash; Pitts Didn't Disclose Ties
- The producer of an NPR radio show has accused the show's host, Fred Goodwin, of breaking his contract by failing to disclose his ties to drug companies. The producer also denies that Peter Pitts, a former FDA official and an executive at Manning, Selvage & Lee, a...
- Blog posts 2009-03-09
- Novartis, Boehringer Start Using Twitter Accounts
- AstraZeneca, Novartis, Vertex Pharmaceuticals and Boehringer Ingelheim have started experimenting with Twitter with varying degrees of enthusiasm, reports Pharmaceutical Executive. Drug companies have so far looked at social media with a mixture of fear and loathing. They believe perhaps wrongly that giving consumers more opportunities to talk...
- Blog posts 2009-02-18
- Drug Makers Gave Lobbyists an Xmas Gift -- Millions More to Lobby Obama Administration
- A New Year will bring a new president, a new FDA chief, many new drug regulations, and, possibly, health insurance reform. Mindful of the ton of major drug brands that will go off-patent in 2009, drug companies have not rested in their lobbying efforts over generics and patent issues. They...
- Blog posts 2008-12-31
- Pharma Roundup: Schering-Plough Surveys Investors, Wyeth Defended, and More
- Schering-Plough shareholders to have say on executive compensation, U.S. drug sales predictions lowered, McCain and Obama both promise hard line on Big Pharma. Also: two lawyers condemn unfounded anti-Wyeth opinions. by John Maas
- Blog posts 2008-10-29
- << Previous
- page 1 of 1
- Next >>
